Found: 36
Select item for more details and to access through your institution.
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 12, p. 5490, doi. 10.1172/JCI72573
- By:
- Publication type:
- Article
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 11, p. 4737, doi. 10.1172/JCI76375
- By:
- Publication type:
- Article
ErbB3 downregulation enhances luminal breast tumor response to antiestrogens.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 10, p. 4329, doi. 10.1172/JCI66764
- By:
- Publication type:
- Article
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 3, p. 1348, doi. 10.1172/JCI65416
- By:
- Publication type:
- Article
Breast cancer resistance mechanisms: challenges to immunotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 1, p. 5, doi. 10.1007/s10549-021-06337-x
- By:
- Publication type:
- Article
Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.844866
- By:
- Publication type:
- Article
Pharmacological Activation of cGAS for Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.753472
- By:
- Publication type:
- Article
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26502-6
- By:
- Publication type:
- Article
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
- Published in:
- Nature Medicine, 2012, v. 18, n. 7, p. 1052, doi. 10.1038/nm.2795
- By:
- Publication type:
- Article
Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Artificial image objects for classification of breast cancer biomarkers with transcriptome sequencing data and convolutional neural network algorithms.
- Published in:
- 2021
- By:
- Publication type:
- journal article
If we build it they will come: targeting the immune response to breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0133-7
- By:
- Publication type:
- Article
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0130-x
- By:
- Publication type:
- Article
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0126-6
- By:
- Publication type:
- Article
Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1778, doi. 10.1111/bcp.14433
- By:
- Publication type:
- Article
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1481, doi. 10.3390/cancers16081481
- By:
- Publication type:
- Article
ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
- Published in:
- BMC Genomics, 2006, v. 7, p. 289, doi. 10.1186/1471-2164-7-289
- By:
- Publication type:
- Article
Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities.
- Published in:
- Immunological Reviews, 2023, v. 318, n. 1, p. 157, doi. 10.1111/imr.13249
- By:
- Publication type:
- Article
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 4, p. 2, doi. 10.1186/s13058-014-0406-x
- By:
- Publication type:
- Article
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The genomic map of breast cancer: which roads lead to better targeted therapies?
- Published in:
- 2013
- By:
- Publication type:
- journal article
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 534, p. 1, doi. 10.1126/scitranslmed.aaw8275
- By:
- Publication type:
- Article
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 334, p. 1, doi. 10.1126/scitranslmed.aad3001
- By:
- Publication type:
- Article
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e835, doi. 10.1093/cid/ciaa1571
- By:
- Publication type:
- Article
Molecular Signatures of Lung Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2012, v. 16, n. 1, p. 1, doi. 10.1007/BF03256423
- By:
- Publication type:
- Article
First-Line Treatment of Metastatic Colorectal Cancer: Focus on Cetuximab in Combination with Chemotherapy.
- Published in:
- Clinical Medicine Reviews in Oncology, 2010, n. 2, p. 319, doi. 10.4137/cmro.s1603
- By:
- Publication type:
- Article
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02630-w
- By:
- Publication type:
- Article
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00728-9
- By:
- Publication type:
- Article
Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute–Designated Comprehensive Cancer Center.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e1962, doi. 10.1002/onco.13936
- By:
- Publication type:
- Article
Severe Epididymo‐Orchitis and Encephalitis Complicating Anti‐PD‐1 Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 872, doi. 10.1634/theoncologist.2018-0722
- By:
- Publication type:
- Article
Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel.
- Published in:
- Oncologist, 2014, v. 19, n. 6, p. 616, doi. 10.1634/theoncologist.2014-0011
- By:
- Publication type:
- Article
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1 AX driver mutations in melanoma and across the cancer spectrum.
- Published in:
- Pigment Cell & Melanoma Research, 2016, v. 29, n. 4, p. 470, doi. 10.1111/pcmr.12482
- By:
- Publication type:
- Article
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109).
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01899-2
- By:
- Publication type:
- Article
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, p. 1, doi. 10.1186/s13058-024-01774-0
- By:
- Publication type:
- Article